be_ixf;ym_202201 d_23; ct_50

Clinical Research Studies

Improving the health of our patients through groundbreaking clinical research.

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Dermatology Clinical Trials

Study: Injectable Treatment to Treat Cutaneous Squamous Cell Carcinoma

Purpose: The purpose of this trial is to evaluate the safety, tolerability, and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma in situskin cancer(isSCC).

Qualifications:

  • Male and Females, 18 years or older
  • Current diagnosis of SCC

Duration: Up to 14 weeks
Location: Hackensack, NJ
Compensation: Up to $785

Interested in participating in our clinical research study? Please click here.


Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

  • Male and Females, 18 – 60 years old
  • Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks
Location: Hackensack, NJ
Compensation: Up to $1,100 if all study visits are completed

Interested in participating in our clinical research study? Please click here.


Study: Alopecia Areata

Purpose: The primary objective of the study is to assess the effects of dose reduction or drug discontinuation subsequent to hair regrowth following 24 weeks of treatment with either 8 mg BID or 12 mg BID of CTP-543 in adult patients with moderate to severe alopecia areata.

Qualifications:

  • Male and Females, ages 18 to 65 inclusive
  • Definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
  • At least 50% scalp hair loss, as defined by a SALT score ≥50, at Screening and Baseline.

Duration: Approx. 52 weeks
Location: Hackensack, NJ
Compensation: $50 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Prurigo Nodularis

Purpose: To evaluate the effect of NAL ER (oral tablet) on itch as assessed by the percentage of Responders (‘response’ is defined as a ≥ 4-point reduction in the 7-day average Worst Itch – Numerical Rating Scale [WI-NRS]).

Qualifications:

  • Male and Females, 18 years or older
  • Must have PN on 2 areas of the body

Duration: Up to 56 weeks
Location: Hackensack, NJ
Compensation: $100 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Atopic Dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

  • Male and Females, ages 18 to 55 years of age
  • Have moderate to severe atopic dermatitis for at least 1 year
  • Failure to improve with topical prescriptions

Duration: 26 weeks/visiting doctor’s office 10 to 12 times
Locations: Hackensack, NJ
Compensation: If all visits are kept, up to $375 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis

Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.

Qualifications:

  • Male and Females, 18 years or older
  • Current diagnosis of Plaque Psoriasis

Duration: Up to 20 weeks
Locations: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

Purpose: To evaluate the clinical efficacy of SofWave treatment to improve acne scars appearance. Eligible patients will receive 3 treatments (4-6 weeks apart) on the facial acne scars using Sofwave System. All patients will return to the clinic for one follow up visit at 3 months post last treatment.

Qualifications:

  • Female and male subjects, ages 22 to 80 years
  • Mild to moderate facial acne scars

Duration: Approx. 6 months
Locations: Hackensack, NJ
Compensation: Up to $120 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Bliss Max – Non-Invasive Body Contouring and Fat Reduction

Purpose: The objective of this clinical study is to evaluate the safety and efficacy of the combined treatment of electronic muscle stimulation, 1064 nm diode laser and pulsed electromagnetic field, vacuum assisted radio frequency for the non-invasive contouring and fat reduction of the abdomen and flanks. Subjects will be randomized to one of three arms as per randomization scheme.

Qualifications:

  • Male and Females, 18 – 65 years old
  • BMI ≤ 30 kg/m2
  • No tattoos on the abdomen or flanks

Duration: Up to 21 weeks
Location: Hackensack, NJ
Compensation: $50 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Histological Evaluation of BTL-899 Device’s Effect on Fat Tissue

Purpose: This study will evaluate the safety and the performance of the BTL-899 study device for non-invasive study treatment reduction of subcutaneous fat. The changes in the fat tissue will be assessed histologically. Study treatment regimen consists of one study treatment and three follow-up visits – 8 hours, 24 hours and one week after the study treatment.

Qualifications:

  • Adults 21 years of age or older
  • BMI ≤ 35 kg/m2

Duration: Up to 1 month
Location: Hackensack, NJ
Compensation: Up to $500 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: L’Oreal Skinceuticals Tripeptide-R Neck Repair Cream in the Cosmetic Improvement of Photo-Aged Skin

Purpose: To evaluate the efficacy and safety of SkinCeuticals Tripeptide-R Neck Repair Cream for photoaged skin on the face and neck. Histologic improvements and immunostains evaluation from pre-treatment to 1 and 3 months after initiation of therapy.

Qualifications:

  • Adults 18 years of age or older
  • Subjects must be willing to discontinue any other skin care products with antioxidants, growth factors and/or hyaluronic acid.

Duration: Up to 3 months
Location: Hackensack, NJ
Compensation: Up to $120 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Acne

Cutera Acne - IRB approved ad

Purpose: To evaluate the safety and efficacy of the investigational Cutera® 1726 nm laser system (also referred to as ‘Alice’) for the treatment of mild to severe acne vulgaris. Subjects will receive three 1726 nm laser treatments at 3 week intervals. Follow-up visits will occur at approximately 10 days post each treatment (via phone) and at 4-, 12-, 26- and 52-weeks post-final treatment.

Qualifications:

  • Female and male subjects, ages 16 to 60 years
  • Fitzpatrick skin types I-IV with mild, moderate, or severe acne vulgaris

Duration: Approx. 18 months
Location: Hackensack, NJ
Compensation: $325
Referral Fee: Help someone you know struggling with acne by referring them. Your referral will qualify you for a $200 bonus.

Interested in participating in our clinical research study? Please click here.

Interested in participating in our clinical research study?

Please click here


What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified providers

To learn more contact: Diana Aranzazu, research@schweigerderm.com, 609-219-5621

About Schweiger Dermatology Group

Schweiger Dermatology Group was founded to help make excellent dermatology care accessible throughout the Northeast. In 2010, Dr. Eric Schweiger started the practice with a single location in Midtown Manhattan. When he saw the need for high-quality dermatology care that did not require weeks or months of waiting to see a qualified provider, his vision of a multi-location practice was born.

Back to Top
>

Receive skincare tips, news and special offers!

Field marked with asterisk (*) is mandatory.